Keynote Address: James Pooley, WIPO
IP & Business Focus: How to maximise the monetization of your patents Bart Van der Stockt, UNILINMatthew Goodwin, UniliverRussia Focus: Natalia Gulyaeva, Hogan Lovells CIS
Europe, the unitary patent and unified courtBelinda Gascoyne, IBMGordon Harris, Wragge & CoDavid Barron, Wragge & CoDavid Rosenberg, GlaxoSmithKlineDoing business in China: Ensure that your patented assets in China are making you moneyQinghong Xu, Lung TinRoya Ghafele, University of Edinburgh & University of OxfordImportant tax take home points for in-house IP counsel: Overview and practical guidePaul Wilmhurst, Charles River AssociatesTom Scott, McDermott Will & Emery
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International